PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G.J; Miller, N.E

doi:10.1016/s0140-6736(75)92376-4

Cited by 2,621Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Miller, G.J, Miller, N.E·1975·The Lancet

DOI 10.1016/s0140-6736(75)92376-4

Open this paper in CoChat — free account

Abstract

The body cholesterol pool increases with decreasing plasma-high-density-lipoprotein (H.D.L.) but is unrelated to the plasma concentrations of total cholesterol and other lipoproteins. This finding supports existing evidence that H.D.L. facilitates the uptake of cholesterol from peripheral tissues and its transport to the liver for catabolism and excretion. Plasma-H.D.L., is reduced in several conditions associated with an increased risk of future ischaemic heart-disease (I.H.D.), namely hypercholesterolaemia, hypertriglyceridaimia, male sex, obesity, and diabetes mellitus, while subjects with existing clinical I.H.D. have lower levels of H.D.L. than healthy subjects within the same community. It is proposed that a reduction of plasma-H.D.L. concentration may accelerate the development of atherosclerosis, and hence I.H.D., by impairing the clearance of cholesterol from the arterial wall.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(75)92376-4

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

There is an inverse relationship between serum HDL levels and the risk of coronary heart disease.
“there is an inverse relationship between serum HDL levels and the risk of coronary heart disease49,50.”
From Perspectives and opportunities for nanomedicine in the management of atherosclerosis (2011) · cites this paper as [49]
Low HDL-C has long been viewed as a robust and independent CVD risk factor.
“For many decades, a low level of HDL-C has been viewed as a robust and independent CVD risk factor1-4.”
From Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor?: New Insights From the Framingham Offspring Study (2016) · cites this paper as [1]

The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,409 · see citing works
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160 · see citing works
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,911 · see citing works
ISCHÆMIC HEART-DISEASE IN RELATION TO FASTING VALUES OF PLASMA TRIGLYCERIDES AND CHOLESTEROL
Carlson, L., & Böttiger, L. E. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90738-6 · Cited by 752 · see citing works
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (1971) · The Lancet · doi:10.1016/s0140-6736(71)91658-8 · Cited by 690 · see citing works
Protein-lipid relationships in human plasma
Barr, D. P., Russ, E. M., & Eder, H. A. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90183-0 · Cited by 635 · see citing works
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
Slack, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90930-1 · Cited by 625 · see citing works
PLASMA LIPID AND LIPOPROTEIN PATTERN IN GREENLANDIC WEST-COAST ESKIMOS
Bang, H. O., Dyerberg, J., & Nielsen, A. B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07607.x · Cited by 604 · see citing works
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701192760305 · Cited by 526 · see citing works
VIGOROUS EXERCISE IN LEISURE-TIME AND THE INCIDENCE OF CORONARY HEART-DISEASE
Morris, J. N., Chave, S. P. W., Adam, C., Sirey, C., Epstein, L. H., & Sheehan, D. J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90128-1 · Cited by 456 · see citing works
Lipoprotein fractionation.
Carlson, K. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.32 · Cited by 420 · see citing works
Serum Lipids in Men with Myocardial Infarction
Carlson, L. A. (1960) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1960.tb03562.x · Cited by 325 · see citing works
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia
Grundy, S. M., AHRENS, E. H., Salen, G., Schreibman, P. H., & Nestel, P. J. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39388-3 · Cited by 301 · see citing works
Turnover of plasma cholesterol in man
Goodman, D. S., & Noble, R. P. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105719 · Cited by 294 · see citing works
Metabolic relationships among the plasma lipoproteins
Wilson, D. E., & Lees, R. S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106896 · Cited by 290 · see citing works
Coronary Heart Disease: Overweight and Obesity as Risk Factors
Keys, A. B., Aravanis, C., BLACKBURN, H. W., van Buchem, F. S. P., Buzina, R., DJORDJEVIC, B. S., Fidanza, F., Karvonen, M. J., Menotti, A., PUDDU, V., et al. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-1-15 · Cited by 243 · see citing works
Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
WALTON, K. W., & Williamson, N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80020-1 · Cited by 237 · see citing works
A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques
Fredrickson, D. S., Levy, R. I., & Lindgren, F. T. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105927 · Cited by 226 · see citing works
Identification of crystals deposited in brain and kidney after xylitol administration by biochemical, histochemical, and electron diffraction methods
Evans, G. W., Phillips, G. E., Mukherjee, T. M., Snow, M. R., LAWRENCE, J. R., & Thomas, D. W. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.26.1.32 · Cited by 225 · see citing works
Cholesterol synthesis in the squirrel monkey: relative rates of synthesis in various tissues and mechanisms of control
Dietschy, J. M., & Wilson, J. D. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105706 · Cited by 223 · see citing works
Distribution and turnover of cholesterol in humans
Nestel, P. J., Whyte, H. M., & Goodman, D. S. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106079 · Cited by 213 · see citing works
RELATIONSHIP BETWEEN LOW-DENSITY LIPOPROTEIN IN AORTIC INTIMA AND SERUM-LIPID LEVELS
Smith, E. B., & Slater, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)90122-5 · Cited by 205 · see citing works
BODY CHOLESTEROL METABOLISM IN MAN. I. THE EQUILIBRATION OF SERUM AND TISSUE CHOLESTEROL*†
Chobanian, A. V., & Hollander, W. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104631 · Cited by 203 · see citing works
The Serum Lipids and Lipoproteins in Normal and Hyperlipidemic Subjects as Determined by Preparative Ultracentrifugation
Furman, R. H., Howard, R. P., LAKSHMI, K., & Norcia, L. N. (1961) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/9.1.73 · Cited by 187 · see citing works
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
Levy, R. I., FREDRICKSON, D. S., SHULMAN, R., BILHEIMER, D. W., Breslow, J. L., STONE, N. J., LUX, S. E., SLOAN, H. R., Krauss, R. M., & HERBERT, P. N. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-2-267 · Cited by 183 · see citing works
Physiological Ce:Roles of Lecithin—Cholesterol Acyltransferase
Glomset, J. A. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.8.1129 · Cited by 183 · see citing works
Cholestyramine Resin Therapy for Hypercholesteremia
Hashim, S. A. (1965) · JAMA · doi:10.1001/jama.1965.03080170017004 · Cited by 171 · see citing works
Human Serum Lipoproteins and Their Interrelationships
Nichols, A. V. (1967) · Advances in biological and medical physics · doi:10.1016/b978-1-4832-3107-5.50008-x · Cited by 170 · see citing works
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
Lewis, B., Wootton, I. D. P., Krikler, D. M., February, A., Chait, A., Oakley, C. M., Sigurdsson, G., Maurer, B., & Birkhead, J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92438-6 · Cited by 165 · see citing works
Acute Effects of Prolonged, Heavy Exercise on the Concentration of Plasma Lipids and Lipoproteins in Man
Carlson, L. A., & Mossfeldt, F. (1964) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1964.tb03951.x · Cited by 163 · see citing works
Erythrocyte metabolism. III. Relationship of energy metabolism and serum factors to the osmotic fragility following incubation
Murphy, J. R. (1962) · Journal of Laboratory and Clinical Medicine · doi:10.5555/uri:pii:0022214362900501 · Cited by 154 · see citing works
Cholesterol Metabolism in Human Obesity
Nestel, P. J., Schreibman, P. H., & AHRENS, E. H. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107428 · Cited by 151 · see citing works
The removal of cholesterol from landschütz ascites cells by high-density apolipoprotein
Stein, O. T., & Stein, Y. (1973) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(73)90249-x · Cited by 141 · see citing works
Factors affecting lipoprotein metabolism.
Scanu, A. M. (1965) · PubMed · Cited by 133 · see citing works
In vitro incorporation of cholesterol-14C in to very low density lipoprotein cholesteryl esters
Akanuma, Y., & Glomset, J. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42709-9 · Cited by 123 · see citing works
Treatment of hyperlipidemias
Strisower, E. H., Adamson, G. L., & Strisower, B. (1968) · The American Journal of Medicine · doi:10.1016/0002-9343(68)90165-4 · Cited by 110 · see citing works
Factors Affecting Lipoprotein Metabolism1 1This work was supported by grants from the Public Health Service (HE 08727-01) and from the Chicago and Illinois Heart Associations.2 2Literature published after June 30, 1964, is not included in this survey.
Scanu, A. M. (1965) · Advances in lipid research · doi:10.1016/b978-1-4831-9939-9.50009-7 · Cited by 99 · see citing works
A STUDY OF SERUM LIPOPROTEINS IN NORMAL AND ATHEROSCLEROTIC PATIENTS BY PAPER ELECTROPHORETIC TECHNIQUES
Jencks, W. P., Hyatt, M. R., Jetton, M. R., Mattingly, T. W., & DURRUM, E. L. (1956) · Journal of Clinical Investigation · doi:10.1172/jci103358 · Cited by 90 · see citing works
CHOLESTEROL FLUX IN THE ATHEROSCLEROTIC PLAQUE*
Zilversmit, D. B. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb53830.x · Cited by 83 · see citing works
SERUM CHOLESTEROL, ELECTROPHORETIC LIPID PATTERN, DIET AND CORONARY ARTERY DISEASE: A STUDY IN CORONARY PATIENTS AND IN HEALTHY MEN OF DIFFERENT ORIGIN AND OCCUPATIONS IN ISRAEL
Brunner, D., & Löbl, K. (1958) · Annals of Internal Medicine · doi:10.7326/0003-4819-49-4-732 · Cited by 79 · see citing works
Epidemiology of coronary heart disease. Implications for the practicing physician.
Kannel, W. B., KAGAN, A., Dawber, T. R., & Revotskie, N. (1962) · PubMed · Cited by 76 · see citing works
Serum cholesterol and relative body weight of coronary patients in different populations
KEYS, A., & FIDANZA, F. (1960) · Circulation · doi:10.1161/01.cir.22.6.1091 · Cited by 74 · see citing works
The status of risk factors and coronary heart disease
Simborg, D. W. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90031-7 · Cited by 63 · see citing works
Improved estimation of body masses and turnover of cholesterol by computerized input–output analysis
Samuel, P., & Lieberman, S. (1973) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36906-6 · Cited by 63 · see citing works
Effects of colestipol, a new bile-acid-sequestering resin, on cholesterol metabolism in man.
Miller, N. E., Clifton-Bligh, P. B., & Nestel, P. J. (1973) · PubMed · Cited by 61 · see citing works
Self-citation
Lipoprotein lipid alterations with cholestyramine administration.
Jones, R. J., & Dobrilovic, L. (1970) · PubMed · Cited by 58 · see citing works
Long-term decay of serum cholesterol radioactivity: body cholesterol metabolism in normals and in patients with hyperlipoproteinemia and atherosclerosis
Samuel, P., & Perl, W. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106243 · Cited by 58 · see citing works
Cholesterol Turnover in Man
Nestel, P. J. (1970) · Advances in lipid research · doi:10.1016/b978-0-12-024908-4.50008-8 · Cited by 56 · see citing works
Long-Term Effects of Clofibrate (Atromid-S) on Serum Lipids in Man
Hunninghake, D. B., Tucker, D. R., & Azarnoff, D. L. (1969) · Circulation · doi:10.1161/01.cir.39.5.675 · Cited by 54 · see citing works
Long-Term Kinetics of Serum and Xanthoma Cholesterol Radioactivity in Patients with Hypercholesterolemia
Samuel, P., Perl, W., Holtzman, C. M., Rochman, N. D., & Lieberman, S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106811 · Cited by 43 · see citing works
Diabetes in 1964: A World Survey
Entmacher, P. S., & Marks, H. H. (1965) · Diabetes · doi:10.2337/diab.14.4.212 · Cited by 42 · see citing works
Incorporation of 14 C-Labeled Acetate into Lipid by Isolated Foam Cells and by Atherosclerotic Arterial Intima
Day, A. J., & Wilkinson, G. K. (1967) · Circulation Research · doi:10.1161/01.res.21.5.593 · Cited by 42 · see citing works
The pathogenesis of atherosclerosis.
Adams, C. W. M. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.38 · Cited by 40 · see citing works
The Efficacy of Clofibrate (CPIB) in Familial Hyperlipoproteinemias
Levy, R. I., Quarfordt, S. H., Brown, W. V., Sloan, H. R., & Fredrickson, D. S. (1969) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-6866-7_31 · Cited by 30 · see citing works
Hypocholesterolemic agents and mobilization of tissue cholesterol in man
Sodhi, H. S., Kudchodkar, B. J., & Horlick, L. (1973) · Atherosclerosis · doi:10.1016/0021-9150(73)90130-5 · Cited by 28 · see citing works
Studies on the Characterization of Human Serum Lipoproteins Separated by Ultracentrifugation in a Density Gradient
Cornwell, D. G., Kruger, F. A., Hamwi, G. J., & Brown, J. B. (1961) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/9.1.41 · Cited by 28 · see citing works
Plasma Lipid and Lipoprotein Levels in Childhood and Adolescence
Dyerberg, J., & Hjørne, N. (1973) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365517309084333 · Cited by 26 · see citing works
Plasma lipid levels and the diagnosis of coronary arteriosclerosis in England.
MILLS, G. L., & Wilkinson, P. A. (1966) · Heart · doi:10.1136/hrt.28.5.638 · Cited by 22 · see citing works
Plasma lipids and atherosclerosis.
Carlson, L. A. (1973) · Journal of Clinical Pathology · doi:10.1136/jcp.s1-5.1.43 · Cited by 13 · see citing works

Flagged first, then by citations

Sorted by citations

High density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059 · see citing works
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,377 · see citing works
Mendelian randomization
Sanderson, E., Glymour, M. M., Holmes, M. V., Kang, H., Morrison, J., Munafò, M. R., Palmer, T., Schooling, C. M., Wallace, C., Zhao, Q., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-021-00092-5 · Cited by 2,229 · see citing works
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780 · see citing works
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547 · see citing works
HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study
Castelli, W. P., Doyle, J. T., Gordon, T., Hames, C. G., Hjortland, M. C., Hulley, S. B., Kagan, A., & Zukel, W. J. (1977) · Circulation · doi:10.1161/01.cir.55.5.767 · Cited by 1,492 · see citing works
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411 · see citing works
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,358 · see citing works
The Bogalusa Heart Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_7 · Cited by 1,331 · see citing works
Cholesterol in the Prediction of Atherosclerotic Disease
Kannel, W. B., Castelli, W. P., & Gordon, T. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-1-85 · Cited by 1,314 · see citing works
A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterol
Warnick, G. R., & Albers, J. J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41577-9 · Cited by 1,250 · see citing works
Prospective study of alcohol consumption and risk of coronary disease in men.
Rimm, E. B., Giovannucci, E. L., Willett, W. C., Colditz, G. A., Ascherio, A., Rosner, B., & Stampfer, M. J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90542-w · Cited by 1,239 · see citing works
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Tangvarasittichai, S. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.456 · Cited by 1,238 · see citing works
High density lipoprotein metabolism.
Eisenberg, S. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37713-0 · Cited by 1,212 · see citing works
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206 · see citing works
Self-citation
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00007 · Cited by 1,022 · see citing works
Dietary influences on serum lipids and lipoproteins.
Grundy, S. M., & Denke, M. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42625-2 · Cited by 1,044 · see citing works
Moderate Alcohol Intake, Increased Levels of High-Density Lipoprotein and Its Subfractions, and Decreased Risk of Myocardial Infarction
Gaziano, J. M., Buring, J. E., Breslow, J. L., Goldhaber, S. Z., ROSNER, B. A., VanDenburgh, M., Willett, W. C., & Hennekens, C. H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292501 · Cited by 1,008 · see citing works
Relation of Gemfibrozil Treatment and Lipid Levels With Major Coronary Events
Robins, S. J., Collins, D. E., Wittes, J. T., Papademetriou, V., DEEDWANIA, P. C., Schaefer, E. J., McNamara, J. R., Kashyap, M. L., Hershman, J. M., WEXLER, L. F., et al. (2001) · JAMA · doi:10.1001/jama.285.12.1585 · Cited by 916 · see citing works
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
Stampfer, M. J., Colditz, G. A., Willett, W. C., Speizer, F. E., & Hennekens, C. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808043190503 · Cited by 892 · see citing works
Serum Lipoproteins and Coronary Heart Disease in a Population Study of Hawaii Japanese Men
Rhoads, G. G., Gulbrandsen, C. L., & Kagan, A. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602052940601 · Cited by 876 · see citing works
The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G. J., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 871 · see citing works
A Prospective Study of Postmenopausal Estrogen Therapy and Coronary Heart Disease
Stampfer, M. J., Willett, W. C., Colditz, G. A., ROSNER, B. A., Speizer, F. E., & Hennekens, C. H. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131703 · Cited by 855 · see citing works
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827 · see citing works
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757 · see citing works
Self-citation
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3
Navab, M., Hama, S. Y., Anantharamaiah, G. M., Hassan, K., Hough, G. P., Watson, A. D., Reddy, S. T., Sevanian, A., Fonarow, G. C., & Fogelman, A. M. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33462-3 · Cited by 663 · see citing works
Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study
Kannel, W. B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90224-8 · Cited by 664 · see citing works
Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?
McLaughlin, T., Reaven, G. M., Abbasi, F., Lamendola, C. A., Saad, M. F., Waters, D. D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 659 · see citing works
Social class and coronary heart disease.
Rose, G., & Marmot, M. G. (1981) · Heart · doi:10.1136/hrt.45.1.13 · Cited by 644 · see citing works
High density lipoprotein cholesterol and mortality. The Framingham Heart Study.
Wilson, P. W. F., Abbott, R. D., & Castelli, W. P. (1988) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.8.6.737 · Cited by 644 · see citing works
PLASMA LIPID TRANSFER PROTEINS
Tall, A. R. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.001315 · Cited by 639 · see citing works
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M. C. D. O., Saraiva, J., Chacra, A., Bianco, H. T., Neto, A. A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A. C., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 660 · see citing works
Characterization of human high-density lipoproteins by gradient gel electrophoresis
Blanche, P. J., Gong, E. L., Forte, T. M., & Nichols, A. V. (1981) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(81)90253-8 · Cited by 614 · see citing works
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 603 · see citing works
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.
Zhong, S., Sharp, D. S., Grove, J., Bruce, C., Yano, K., Curb, J. D., & Tall, A. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118751 · Cited by 582 · see citing works
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
Carlson, L. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01528.x · Cited by 586 · see citing works
Coronary heart disease in South Asians overseas: A review
McKeigue, P. (1989) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(89)90002-4 · Cited by 579 · see citing works
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C. A., McLaughlin, T., & Reaven, G. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02051-x · Cited by 574 · see citing works
Insulin and Atheroma: 20-Yr Perspective
Stout, R. W. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.631 · Cited by 568 · see citing works
A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum.
Chapman, M. J., Goldstein, S., Lagrange, D., & Laplaud, P. M. (1981) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35376-1 · Cited by 553 · see citing works
Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor.
Chung, B. H., Wilkinson, T., Geer, J. C., & Segrest, J. P. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39807-2 · Cited by 546 · see citing works
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537 · see citing works
Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome
Grundy, S. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00033-2 · Cited by 525 · see citing works
Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.
Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkand, B. M., Schonfeld, G., Jacobs, D., & Frantz, I. D. (1980) · Circulation · doi:10.1161/01.cir.61.2.302 · Cited by 526 · see citing works
Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.
Groot, P. H. E., van Stiphout, W. A. H. J., Krauss, X. H., Jansen, H., van Tol, A., van Ramshorst, E., Chin-On, S., Albert Hofman, D., Cresswell, S. R., & Havekes, L. M. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.653 · Cited by 528 · see citing works
Macrophage Reverse Cholesterol Transport
Cuchel, M., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.104.475715 · Cited by 529 · see citing works
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523 · see citing works
LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
Hessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505 · see citing works
The Primary Prevention of Myocardial Infarction
Manson, J. E., Tosteson, H., Ridker, P. M., Satterfield, S., Hebert, P., O'Connor, G. T., Buring, J. E., & Hennekens, C. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262107 · Cited by 504 · see citing works
Plasma High-Density Lipoproteins
Tall, A. R., & SMALL, D. M. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811302992207 · Cited by 500 · see citing works
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M., Harty, D. W. S., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492 · see citing works
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study.
Lemieux, I., Lamarche, B., Couillard, C., Pascot, A., Cantin, B., Bergeron, J., Dagenais, G., & Despres, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.22.2685 · Cited by 551 · see citing works
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485 · see citing works
Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales.
Balarajan, R. (1991) · BMJ · doi:10.1136/bmj.302.6776.560 · Cited by 484 · see citing works
ABCA1: the gatekeeper for eliminating excess tissue cholesterol
Oram, J. F., & Lawn, R. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31566-2 · Cited by 481 · see citing works
A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
Franceschini, G., Sirtori, C. R., Capurso, A., Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109956 · Cited by 470 · see citing works
Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I
Shepherd, J., Packard, C. J., Patsch, J. R., Gotto, A. M., & Taunton, O. D. (1978) · Journal of Clinical Investigation · doi:10.1172/jci109078 · Cited by 456 · see citing works
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H.-J., & Beisiegel†, U. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.579 · Cited by 446 · see citing works
Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation
Borhani, D. W., Rogers, D. P., Engler, J. A., & Brouillette, C. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12291 · Cited by 434 · see citing works
The metabolic syndrome: requiescat in pace
Reaven, G. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048611 · Cited by 427 · see citing works
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423 · see citing works
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Martin, G., Duez, H., Blanquart, C., Bérézowski, V., Poulain, P., Fruchart, J., Najib-Fruchart, J., Glineur, C., & Staels, B. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10852 · Cited by 417 · see citing works
Multifactorial causation of obesity: implications for prevention
Grundy, S. M. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.3.563s · Cited by 403 · see citing works
The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: An Approach to Accurate and Precise Lipid Measurements
Myers, G. L., Cooper, G. R., Winn, C., & Smith, S. J. (1989) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30645-0 · Cited by 404 · see citing works
High-density lipoprotein revisited: biological functions and clinical relevance
von Eckardstein, A., Nordestgaard, B. G., Remaley, A. T., & Catapano, A. L. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac605 · Cited by 401 · see citing works
Insulin resistance: the link between obesity and cardiovascular disease.
Reaven, G. (2011) · The Medical clinics of North America · doi:10.1016/j.mcna.2011.06.002 · Cited by 458 · see citing works
Effects of ethanol on lipid metabolism.
Baraona, E., & Lieber, C. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40613-3 · Cited by 392 · see citing works
Isolated Low HDL Cholesterol As a Risk Factor for Coronary Heart Disease Mortality
Goldbourt, U., Yaari, S., & Medalie, J. H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.107 · Cited by 390 · see citing works
PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA
Thompson, G. R., Lowenthal, R. M., & Myant, N. B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92193-5 · Cited by 390 · see citing works
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
Abbott, C. A., Mackness, M., Kumar, S., Boulton, A. J. M., & Durrington, P. N. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1812 · Cited by 387 · see citing works
Plasma Sphingomyelin Level as a Risk Factor for Coronary Artery Disease
Jiang, X.-C., Paultre, F., Pearson, T. A., Reed, R. G., Francis, C. K., Lin, M., Berglund, L., & Tall, A. R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.12.2614 · Cited by 387 · see citing works
Coronary risk prediction in adults (The Framingham Heart Study)
Wilson, P. W. F., Castelli, W. P., & Kannel, W. B. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90165-2 · Cited by 381 · see citing works
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Cheung, M. C., & Albers, J. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108767 · Cited by 381 · see citing works
High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.
Patsch, J. R., Prasad, S. C., Gotto, A. M., & Patsch, W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113078 · Cited by 377 · see citing works
Plasma lipid transfer proteins.
Tall, A. R. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38819-2 · Cited by 377 · see citing works
Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification
Mackness, B., Mackness, M., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 376 · see citing works
The metabolic syndrome: time for a critical appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2005) · Diabetologia · doi:10.1007/s00125-005-1876-2 · Cited by 373 · see citing works
Diabetes, Blood Lipids, and the Role of Obesity in Coronary Heart Disease Risk for Women
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-393 · Cited by 368 · see citing works
The distribution of plasma lipoproteins in middle-aged male runners
Wood, P. D., Haskell, W. L., Klein, H., Lewis, S. F., D, M. P. S. M., & Farquhar, J. W. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80008-x · Cited by 363 · see citing works
Plasma Lipids and Lipoproteins in Vegetarians and Controls
Sacks, F. M., Castelli, W. P., Donner, A., & Kass, E. H. (1975) · New England Journal of Medicine · doi:10.1056/nejm197505292922203 · Cited by 356 · see citing works
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354 · see citing works
Self-citation
Increased exercise level and plasma lipoprotein concentrations: A one-year, randomized, controlled study in sedentary, middle-aged men
Wood, P. D., Haskell, W. L., Blair, S. N., Williams, P. T., Krauss, R. M., Lindgren, F. T., Albers, J. J., Ho, P., & Farquhar, J. W. (1983) · Metabolism · doi:10.1016/0026-0495(83)90152-x · Cited by 352 · see citing works
Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography.
Weisgraber, K. H., & Mahley, R. W. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39811-4 · Cited by 347 · see citing works
Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy
Hirvonen, E., Mälkönen, M., & Manninen, V. (1981) · New England Journal of Medicine · doi:10.1056/nejm198103053041002 · Cited by 345 · see citing works
Untitled work
(1981) · PubMed · Cited by 341 · see citing works
Human plasma phospholipid transfer protein causes high density lipoprotein conversion.
Jauhiainen, M., Metso, J., Pahlman, R., Blomqvist, S., van Tol, A., & Ehnholm, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53575-4 · Cited by 342 · see citing works
Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
Oram, J. F., & Yokoyama, S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37453-8 · Cited by 342 · see citing works
Quantitation of apolipoprotein A-I of human plasma high density lipoprotein
Albers, J. J., WAHL, P. W., Cabana, V. G., Hazzard, W. R., & Hoover, J. (1976) · Metabolism · doi:10.1016/0026-0495(76)90060-3 · Cited by 342 · see citing works
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works
The Effects of Estrogen Administration on Plasma Lipoprotein Metabolism in Premenopausal Females
Schaefer, E. J., Foster, D. M., Zech, L. A., Lindgren, F. T., Brewer, H. B., & Levy, R. I. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-262 · Cited by 337 · see citing works
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
Navab, M., Hama, S. Y., Hough, G. P., Subbanagounder, G., Reddy, S. T., & Fogelman, A. M. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31582-0 · Cited by 334 · see citing works
Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease
Genest, J. J., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Silberman, S. R., Anderson, K. M., Wilson, P. W. F., Salem, D. N., & Schaefer, E. J. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90520-w · Cited by 333 · see citing works
Oxidation of High Density Lipoproteins
Garner, B., Waldeck, A. R., Witting, P. K., Rye, K.-A., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6088 · Cited by 324 · see citing works
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study
Sacco, R. L., Benson, R. T., Kargman, D. E., Boden-Albala, B., Tuck, C., Lin, I.-F., Cheng, J. F., Paik, M. C., Shea, S., & Berglund, L. (2001) · JAMA · doi:10.1001/jama.285.21.2729 · Cited by 311 · see citing works
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1195 · Cited by 312 · see citing works
Cigarette smoking and HDL cholesterol the Framingham offspring study
Garrison, R. J., Kannel, W. B., Feinleib, M., Castelli, W. P., Pm, M., & Padgett, S. J. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90149-1 · Cited by 311 · see citing works
Lipid Metabolism and Ischemic Heart Disease in Greenland Eskimos
Bang, H. O., & Dyerberg, J. (1980) · Springer eBooks · doi:10.1007/978-1-4757-4448-4_1 · Cited by 304 · see citing works
Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery Disease
Norum, R. A., Lakier, J. B., Goldstein, S., Angel, A., Goldberg, R. B., Block, W. D., Noffze, D. K., Dolphin, P. J., Edelglass, J. W., Bogorad, D. D., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198206243062503 · Cited by 303 · see citing works
The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
Mackness, M., Abbott, C. A., Arrol, S., & Durrington, P. N. (1993) · Biochemical Journal · doi:10.1042/bj2940829 · Cited by 304 · see citing works

PLASMA-TRIGLYCERIDES IN REGULATION OF H.D.L.-CHOLESTEROL LEVELS
Schaefer, E. J., Anderson, D. W., Brewer, H. B., Levy, R. I., Danner, R., & Blackwelder, W. C. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91863-9 · Cited by 196 · see citing works
Regulation of Plasma High Density Lipoprotein Concentration by Lipoprotein Lipase and Hepatic Endothelial Lipase
Nikkilä, E. A. (1984) · Springer eBooks · doi:10.1007/978-1-4757-1824-9_32
Coronary Atherosclerosis and Plasma Lipoproteins
Miller, N. E. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198200042-00002 · Cited by 25 · see citing works
Self-citation
Plasma High-Density Lipoproteins and Ischemic Heart Disease
Streja, D. A., Steiner, G. A., & Kwiterovich, P. O. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-6-871 · Cited by 90 · see citing works
The significance of elevated plasma lipids in relation to the prevention of ischaemic heart disease.
Mf, O. (1962) · Europe PMC (PubMed Central) · Cited by 4 · see citing works

Authors: Miller, G. J., & Miller, N. E.
Affiliations: University Hospital Llandough (GB)
Edinburgh Royal Infirmary (GB)
ORCID: Miller, G.J
Venue: The Lancet
Publisher: Elsevier BV
Published: 1975-01
Volume: 305
Issue: 7897
Pages: 16-19
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(75)92376-4
OpenAlex: W1994967652
Cited by: 2,621
References: 59
Citations by year: 2026: 5 · 2025: 11 · 2024: 9 · 2023: 7 · 2022: 15 · 2021: 17 · 2020: 24 · 2019: 18 · 2018: 18 · 2017: 17 · 2016: 29 · 2015: 29 · 2014: 22 · 2013: 32 · 2012: 26
FWCI: 157.87
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: high-density lipoprotein, ischemic heart disease, atherosclerosis, cholesterol metabolism, hypercholesterolemia, hypertriglyceridemia, obesity, diabetes mellitus, sex differences, cardiovascular risk factors
MeSH terms: Arteries, Arteriosclerosis, Cholesterol, Coronary Disease, Denmark, Inuit, Female, Finland, Humans, Lipoproteins, HDL, Lipoproteins, LDL, Lipoproteins, VLDL, Liver, Male, Middle Aged, Sex Factors, Sweden, Triglycerides, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Cites

Cited by

Related

Record

About these checks